Playback speed
10 seconds
Management of Acute ILD Exacerbation (AE-IPF): Does Rituximab Provide Beneficial Effects for IPF Patients? What Is the Efficacy of Autoantibody Reduction Therapies?
By
Advanced Lung Disease Conference 2020
FEATURING
Steven Duncan
By
Advanced Lung Disease Conference 2020
FEATURING
Steven Duncan
667 views
February 2, 2021
Login to view comments.
Click here to Login